Corcept Therapeutics (CORT) Posts Wider than Expected Q4 loss of 12c/Share

March 5, 2012 9:15 AM

Corcept Therapeutics, Inc. (NASDAQ: CORT) reported Q4 EPS of ($0.12), $0.03 worse than the analyst estimate of ($0.09).

For earnings history and earnings-related data on Corcept Therapeutics, Inc. (CORT) click here.

No results found